CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1
Molecular Carcinogenesis · 2023
DOI: 10.1002/mc.23599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2023. Verfasst von Biao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
CCR4‐NOT transcription complex subunit 4 (CNOT4) and RNA polymerase II‐associated factor, homolog ( Saccharomyces cerevisiae ) (PAF1) are implicated in nonsmall cell lung cancer (NSCLC). However, the molecular mechanism of their interaction in NSCLC progression is unknown. The expression of PAF1 and CNOT4 in human NSCLC tissues was detected by quantitative polymerase chain reaction. A549 cells that stably expressed CNOT4 and/or PAF1 were established. Western blot analysis and co‐immunoprecipitation experiments were performed to reveal the interaction between CNOT4 and PAF1. Proliferation, migration, epithelial–mesenchymal transition (EMT), and colony formation assays were performed to determine the effect of CNOT4‐PAF1 axis on NSCLC metastasis and stemness. Xenograft mouse tumor model was established, and tumor progression, EMT, and stemness were evaluated. It was found that CNOT4 expression was downregulated, whereas PAF1 expression was upregulated in human NSCLC tissues. CNOT4 facilitated the ubiquitination and degradation of PAF1 via the 26S proteasome. CNOT4 overexpression inhibited NSCLC progression, whereas PAF1 overexpression enhanced the proliferation, migration, and stemness of NSCLC, both in vitro and in vivo. Our results suggest that CNOT4‐PAF1 axis modulates NSCLC metastasis and stemness, and may serve as potential therapeutic targets for lung cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Pharmacy, Weifang Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
- Department of Thoracic Surgery, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.
Zitieren
APA
Zhang, B., Zhao, B., Han, S., & Chen, S. (2023). CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23599
Vancouver
Zhang B, Zhao B, Han S, Chen S. CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1. Molecular Carcinogenesis. 2023. doi:10.1002/mc.23599
BibTeX
@article{Zhang2023,
author = {Zhang, Biao and Zhao, Bin and Han, Song and Chen, Shaomu},
title = {CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1},
journal = {Molecular Carcinogenesis},
year = {2023},
doi = {10.1002/mc.23599}
}
EUVIMED